학술논문

Repurposing pentamidine using hyaluronic acid-based nanocarriers for skeletal muscle treatment in myotonic dystrophy.
Document Type
Abstract
Source
Nanomedicine: Nanotechnology, Biology & Medicine; Jan2023, Vol. 47, pN.PAG-N.PAG, 1p
Subject
MYOBLASTS
MYOTONIA atrophica
NANOCARRIERS
DRUG repositioning
MUSCLE cells
MUSCULAR dystrophy
Language
ISSN
15499634
Abstract
Copyright of Nanomedicine: Nanotechnology, Biology & Medicine is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)